人类疾病中的铁:基本作用和新兴的治疗前景
Ilaria Artusi1,2, Michela Rubin1, Giovanni Cravin1
1Department of Molecular Medicine (DMM), University of Padua, Via Ugo Bassi 58/B, 35131 Padua, Italy.
Antioxidants (Basel, Switzerland)
|December 30, 2025
概括
铁,一种由铁驱动的细胞死亡,是疾病的关键. 它的治疗用途取决于疾病背景,有前途,但面临翻译挑战.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 铁亡是一种对铁敏感的新型调节细胞死亡 (RCD) 途径.
- 它涉及脂质过氧化,铁不平衡,以及保护系统的缺陷,如GPx4.
- 铁亡被认为是许多人类疾病的中心病理机制因素.
研究的目的:
- 审查铁驱动性铁死在人类疾病中的作用.
- 讨论调节铁灭的治疗潜力和挑战.
- 探索未来铁灭症研究和治疗开发的方向.
主要方法:
- 关于铁死机制和疾病关联的文献综述.
- 对针对铁亡的现有和新兴治疗策略的分析.
- 讨论临床翻译方面的挑战和未来的研究途径.
主要成果:
- 诱导铁质可以通过增强抗瘤免疫力,在癌症治疗中有益.
- 抑制铁亡对于管理退行性疾病和急性损伤至关重要.
- 目前的治疗方法包括铁化剂,脂质氧化抑制剂和GPx4激活剂.
结论:
- 铁灭症的治疗调节高度依赖上下文.
- 在开发特定的化向剂和可靠的生物标志物方面,仍然存在重大挑战.
- 未来的研究应该专注于病原体感染,新型调节剂和个性化医疗方法.
相关概念视频
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Overview of Cell Death
9.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.2K
Role of Reduced Coenzymes NADH and FADH₂
16.1K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
16.1K
Types of Intermediate Filaments
4.6K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
4.6K
Introduction to Fibroblasts
3.8K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.8K
Electron Transport Chain: Complex I and II
18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.3K

